Effectiveness of Switching to Darunavir/Cobicistat in Virologically Suppressed HIV-Positive Patients Receiving Ritonavir-Boosted Protease Inhibitor–Based Regimen: The “STORE” Study

OBJECTIVE: This study investigates the effectiveness and tolerability of switching to a darunavir/cobicistat (DRV/c)-based antiretroviral regimen from a ritonavir-boosted protease inhibitor (PI/r)-based regimen in virologically suppressed HIV-positive patients. DRV trough values were also investigat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Acquir Immune Defic Syndr
Main Authors: Gori, Andrea, Antinori, Andrea, Vergori, Alessandra, Cossu, Maria Vittoria, Menzaghi, Barbara, Sterrantino, Gaetana, Rusconi, Stefano, Cattelan, Anna Maria, Castelli, Francesco, Gianotti, Nicola, Orofino, Giancarlo, Ripamonti, Diego, Savinelli, Stefano, Manzillo, Elio, Santantonio, Teresa Antonia, Celesia, Benedetto Maurizio, Cauda, Roberto, Maserati, Renato, d'Arminio Monforte, Antonella, Stingone, Christof, Bonora, Stefano, Uglietti, Alessia, Termini, Roberta, Rucci, Francesco, Mancusi, Daniela
Formato: Artigo
Idioma:Inglês
Publicado em: JAIDS Journal of Acquired Immune Deficiency Syndromes 2020
Assuntos:
Clinical Science
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7289135/
https://ncbi.nlm.nih.gov/pubmed/32101882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000002331
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados